Real-world effectiveness and safety of omalizumab in patients with uncontrolled severe allergic asthma from the Czech Republic

INTRODUCTION: This was a sub-group analysis of patients with uncontrolled persistent allergic asthma (AA) in the healthcare setting of the Czech Republic, from a global non-interventional, 2-year post-marketing, observational eXpeRience registry. AIM: To evaluate the real-life effectiveness and safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirchnerová, Olga Růžičková, Valena, Tomáš, Novosad, Jakub, Teřl, Milan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409880/
https://www.ncbi.nlm.nih.gov/pubmed/30858777
http://dx.doi.org/10.5114/ada.2018.76606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409880/
https://www.ncbi.nlm.nih.gov/pubmed/30858777
http://dx.doi.org/10.5114/ada.2018.76606

Ejemplares similares